Klinikum der Ludwigs-Maximilians-Universität München

München 80337

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma — Completed